A new assessment tool for parkinson disease: The nigral lesion load obtained by transcranial sonography

Journal of Ultrasound in Medicine

Volumn 33, Issue 9, 2014, Pages 1635-1640

  Sanzaro, Enzo ^a   Iemolo, Francesco ^a,b   Duro, Giovanni ^b   Malferrari, Giovanni ^c  

^a Hospital R Guzzardi of Vittoria   (Italy)

^b CNR   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Parkinson disease; Single photon emission computed tomography; Sonography; Substantia nigra; Transcranial sonography

Indexed keywords

MAGNETIC RESONANCE IMAGING; PARTICLE BEAMS; PHOTONS; ULTRASONOGRAPHY;

BIOLOGICAL MARKERS; ECHOGENICITY; NEW APPROACHES; NEW ASSESSMENT TOOLS; PARKINSON DISEASE; SONOGRAPHIC; SUBSTANTIA NIGRA; TRANSCRANIAL SONOGRAPHY;

SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

AGED; BRAIN MAPPING; DOPPLER ECHOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; PARKINSON DISEASE; PROCEDURES; SUBSTANTIA NIGRA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN MAPPING; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SUBSTANTIA NIGRA; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84907195188     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/ultra.33.9.1635     Document Type: Article

References (22)

1. Berg D, Becker G, Zeiler B, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999; 53: 1026-1031.
2. Behnke S, Berg D, Naumann M, Becker G. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 2005; 76: 423-425.
3. Kolevski G, Petrov I, Petrova V. Transcranial sonography in the evaluation of Parkinson disease. J Ultrasound Med 2007; 26: 509-512.
4. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol 2008; 7: 1044-1055.
5. Walter U, Behnke S, Eyding J, et al. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol 2007; 33: 15-25.
6. Fernandes Rde C, Rosso AL, Vincent MB, et al. Transcranial sonography as a diagnostic tool for Parkinson's disease: a pilot study in the city of Rio de Janeiro, Brazil. Arq Neuropsiquiatr 2011; 69: 892-895.
7. Mehnert S, Reuter I, Schepp K, Maaser P, Stolz E, Kaps M. Transcranial sonography for diagnosis of Parkinson's disease. BMC Neurol 2012; 10: 9.
8. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995; 45: 182-184.
9. Van de Loo S, Walter U, Behnke S, et al. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2010; 81: 1087-1092.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
11. Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
12. Felten DL, Jozefowicz RF. Netter's Atlas of Human Neuroscience. New York, NY: Elsevier Saunders; 2003
13. Bergman RA, Thompson SA, Afifi AK, Saadeh FA. Compendium of Human Anatomic Variation: Catalog, Atlas and World Literature. Baltimore, MD: Urban & Schwarzenberg; 1988.
14. Sanzaro E, Iemolo F, Duro G. Brain parenchyma sonography in parkinson's disease and other movement disorders. In: Proceedings of the 52th Congress of the Italian Society of Hospital Neurologists, Neurosurgeons and Neuroradiologists. Tornio, Italy; Edizioni Minerva Medica; 2012: 83-85.
15. Spiegel J, Hellwig D, Mollers MO, et al. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 2006; 129: 1188-1193.
16. Weise D, Lorenz R, Schliesser M, Schirbel A, Reiners K, Classen J. Substantia nigra echogenicity: a structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease. Mov Disord 2009; 24: 1669-1675.
17. Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001; 8: 684-689.
18. Bartova P, Skoloudik D, Ressner P, Langova K, Herzig R, Kanovsky P. Correlation between substantia nigra features detected by sonography and Parkinson disease symptoms. J Ultrasound Med 2010; 29: 37-42.
19. Martin WR, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology2008; 70: 1411-1417.
20. Michell AW, Lewis SJG, Foltynie T, Barker RA. Biomarkers and Parkinson's disease. Brain 2004; 127: 1693-1705.
21. Zecca L, Berg D, Arzberger T, et al. In vivo detection of iron and neuro - melanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 2005; 20: 1278-1285.
22. Gaenslen A, Unmuth B, Godau J, et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 2008; 7: 417-424.